Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 3—March 2011
Research

Mycobacterium tuberculosis Cluster with Developing Drug Resistance, New York, New York, USA, 2003–2009

Bianca R. PerriComments to Author , Douglas C. Proops, Patrick K. Moonan, Sonal S. Munsiff, Barry N. Kreiswirth, Natalia Kurepina, Christopher Goranson, and Shama D. Ahuja
Author affiliations: Author affiliations: New York City Department of Health and Mental Hygiene, New York, New York, USA (B.R. Perri, D. Proops, S.S. Munsiff, C. Goranson, S.D. Ahuja); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (B.R. Perri, P.K. Moonan, S.S. Munsiff); Public Health Research Institute Tuberculosis Center, Newark, New Jersey, USA (B.N. Kreiswirth, N. Kurepina)

Main Article

Figure 1

Cluster of 54 cases of tuberculosis (TB), by year of diagnosis, New York, New York, USA, 2003–2009. The 54 cases include 1 in a patient in the city of New York who was given a diagnosis of drug-susceptible Mycobacterium tuberculosis infection in 2007 that was counted by New York State.

Figure 1. Cluster of 54 cases of tuberculosis (TB), by year of diagnosis, New York, New York, USA, 2003–2009. The 54 cases include 1 in a patient in the city of New York who was given a diagnosis of drug-susceptible Mycobacterium tuberculosis infection in 2007 that was counted by New York State.

Main Article

Page created: July 25, 2011
Page updated: July 25, 2011
Page reviewed: July 25, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external